Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial.

Wang, Guiqiang; Zhao, Kexin; Han, Jun; Hu, Zhongyu; Zhang, Tianzuo; Wang, Yanchao; Shi, Rui; Li, Yanhua; Song, Qinqin; Du, Haijun; He, Peng; Xu, Shuping; Yang, Xinjie; Fu, Yongpan; Cui, Yimin; Xie, Liangzhi

Wang, Guiqiang; Zhao, Kexin; Han, Jun; Hu, Zhongyu; Zhang, Tianzuo; Wang, Yanchao; Shi, Rui; Li, Yanhua; Song, Qinqin; Du, Haijun; He, Peng; Xu, Shuping; Yang, Xinjie; Fu, Yongpan; Cui, Yimin; Xie, Liangzhi.

Wang G; Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital; Department of Infectious Disease, Peking University International Hospital, Beijing, China.
Zhao K; Hebei Petro China Central Hospital, Langfang, China.
Han J; State Key Laboratory of Infectious, Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Hu Z; National Institutes for Food and Drug Control, Beijing, China.
Zhang T; Hebei Petro China Central Hospital, Langfang, China.
Wang Y; Hebei Petro China Central Hospital, Langfang, China.
Shi R; Hebei Petro China Central Hospital, Langfang, China.
Li Y; Hebei Petro China Central Hospital, Langfang, China.
Song Q; State Key Laboratory of Infectious, Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Du H; State Key Laboratory of Infectious, Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
He P; National Institutes for Food and Drug Control, Beijing, China.
Xu S; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd, Beijing, China.
Yang X; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd, Beijing, China.
Fu Y; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd, Beijing, China.
Cui Y; Department of Pharmacy, Peking University First Hospital; Institute of Clinical Pharmacology, Peking University Beijing, China. Electronic address: cui.pharm@pkufh.com.
Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd, Beijing, China; Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Electronic address: LX@sinocelltech.com.

J Infect ; 2022 Nov 17.

Artículo en Inglés | MEDLINE | ID: covidwho-2236786

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tipo de estudio: Estudio experimental / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Idioma: Inglés Año: 2022 Tipo del documento: Artículo País de afiliación: J.jinf.2022.11.008

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google